STAR Clinical Trial Update
The STAR clinical trial is designed to study the
use of a patient’s own Adipose Derived Regenerative Cells (ADRCs), prepared using
the investigational Celution® Device, in the treatment of scleroderma affecting
the hands and fingers. The trial is currently active with patients being enrolled and treated. The majority of centers in the trial are ready to enroll patients and all centers should be active by the end of January.
Click here for more information and center locations
Atorvastatin For Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma
The purpose of this study is to learn about the effect atorvastatin on blood vessel function and Raynaud symptoms in patients with early diffuse systemic sclerosis. This trial is designed to look
at patients with less than 3 years of systemic sclerosis, and patients must
have or had diffuse skin thickening. This study is being performed at the UPMC and University of Pittsburgh Scleroderma Center.
For more information on this study, please
contact one of our Research Coordinators, Dana Ivanco at 412-648-7040, email@example.com or Maureen Laffoon at
Click here to read more about the study >>